- Home
- HBAN vs BNTX Comparison
HBAN vs BNTX Comparison
Compare HBAN & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HBAN | BNTX |
|---|---|---|
| Founded | 1866 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.0B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | HBAN | BNTX |
|---|---|---|
| Price | $17.34 | $95.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 11 |
| Target Price | $19.28 | ★ $137.40 |
| AVG Volume (30 Days) | ★ 20.9M | 1.4M |
| Earning Date | 01-16-2026 | 11-03-2025 |
| Dividend Yield | ★ 3.57% | N/A |
| EPS Growth | ★ 38.74 | N/A |
| EPS | ★ 1.43 | N/A |
| Revenue | ★ $7,502,000,000.00 | $3,698,814,972.00 |
| Revenue This Year | $20.84 | $2.03 |
| Revenue Next Year | $31.04 | N/A |
| P/E Ratio | $12.13 | ★ N/A |
| Revenue Growth | ★ 12.14 | 3.70 |
| 52 Week Low | $11.92 | $81.20 |
| 52 Week High | $18.04 | $129.27 |
Technical Indicators
Market Signals| Indicator | HBAN | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.64 | 45.84 |
| Support Level | $17.51 | $94.00 |
| Resistance Level | $17.95 | $95.71 |
| Average True Range (ATR) | 0.26 | 1.74 |
| MACD | -0.08 | 0.52 |
| Stochastic Oscillator | 0.00 | 62.66 |
Price Performance
Historical ComparisonAbout HBAN Huntington Bancshares Incorporated
Huntington is a regional US bank with around $208 billion in assets and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.